These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8877591)

  • 1. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats.
    Booth BP; Jacob S; Bauer JA; Fung HL
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):432-8. PubMed ID: 8877591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prazosin potentiates the acute hypotensive effects of nitroglycerin but does not attenuate nitrate tolerance in normal conscious rats.
    Wang EQ; Fung HL
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):341-6. PubMed ID: 15076216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
    Takaoka A; Nakae I; Takahashi M; Matsumoto T; Liu Q; Mitsunami K; Kinoshita M
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):231-9. PubMed ID: 9475264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet nitric oxide and superoxide release during the development of nitrate tolerance: effect of supplemental ascorbate.
    McVeigh GE; Hamilton P; Wilson M; Hanratty CG; Leahey WJ; Devine AB; Morgan DG; Dixon LJ; McGrath LT
    Circulation; 2002 Jul; 106(2):208-13. PubMed ID: 12105160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cDNA microarray analysis of vascular gene expression after nitric oxide donor infusions in rats: implications for nitrate tolerance mechanisms.
    Wang EQ; Lee WI; Brazeau D; Fung HL
    AAPS PharmSci; 2002; 4(2):E10. PubMed ID: 12102619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure.
    Bauer JA; Fung HL
    J Pharmacol Exp Ther; 1991 Jan; 256(1):249-54. PubMed ID: 1899118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function is inhibited by nitric oxide liberation during nitroglycerin-induced hypotension anaesthesia.
    Aoki H; Inoue M; Mizobe T; Harada M; Imai H; Kobayashi A
    Br J Anaesth; 1997 Oct; 79(4):476-81. PubMed ID: 9389267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent inhibition of platelets during continuous nitroglycerin therapy despite hemodynamic tolerance.
    Hébert D; Xiang JX; Lam JY
    Circulation; 1997 Mar; 95(5):1308-13. PubMed ID: 9054864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide.
    Amano M; Takahashi M; Kosaka T; Kinoshita M
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):860-6. PubMed ID: 7898066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity.
    Hébert D; Lam JY
    J Am Coll Cardiol; 2000 Dec; 36(7):2311-6. PubMed ID: 11127478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris.
    Chirkov YY; Naujalis JI; Sage RE; Horowitz JD
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):384-9. PubMed ID: 7681498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitroglycerin tolerance at the platelet level in patients with angina pectoris.
    Chirkov YY; Chirkova LP; Horowitz JD
    Am J Cardiol; 1997 Jul; 80(2):128-31. PubMed ID: 9230146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs.
    Kuromaru O; Sakai K
    Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of in vivo nitroglycerin tolerance in normal conscious rats: effects of dose and dosing protocol.
    Wang EQ; Balthasar JP; Fung HL
    Pharm Res; 2004 Jan; 21(1):114-20. PubMed ID: 14984265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation.
    Chirkov YY; Horowitz JD
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):375-80. PubMed ID: 8877583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress.
    Minamiyama Y; Takemura S; Hai S; Suehiro S; Okada S
    Free Radic Biol Med; 2006 Mar; 40(5):808-16. PubMed ID: 16520233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel tolerance between platelet cyclic GMP and preload effects of nitroglycerin in anaesthetized mini-pigs.
    Baines CP; Szwarc RS; Ball HA
    Br J Pharmacol; 1994 Oct; 113(2):334-5. PubMed ID: 7834179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroglycerin-induced relaxation of anorectal smooth muscle: evidence for apparent lack of tolerance development in the anaesthetized rat.
    Wang EQ; Soda DM; Fung HL
    Br J Pharmacol; 2001 Sep; 134(2):418-24. PubMed ID: 11564661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function.
    Pizzulli L; Hagendorff A; Zirbes M; Jung W; Lüderitz B
    Am J Cardiol; 1997 Jan; 79(1):28-33. PubMed ID: 9024731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.